Funded Tech Companies
Vevo Therapeutics
Researching who provided funding to Vevo Therapeutics? General Catalyst Partners, AIX Ventures and Wing Venture Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Vevo Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
953 Indiana St
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Vevo Therapeutics is a biotechnology company using its in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients. The company's Mosaic platform is the first to make in vivo data generation scalable, with single-cell precision, to capture in vivo context of disease at the first step of drug discovery and to better represent patient diversity in drug response over current in vitro assays. Vevo is using Mosaic to build the world's largest in vivo atlas of how drugs interact with patient cells and training AI models on its data to find novel targets and drugs undetectable by other technologies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/8/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nima Alidoust
Chief Scientific Officer
Johnny Yu
Co-Founder
Hani Goodarzi
Co-Founder
Kevan Shokat
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs